The challenge of an increasingly expensive blood system.

This publication has 9 references indexed in Scilit:

• Red blood cell transfusions in critically ill patients.
  JAMA, 2002
• The effectiveness of interventions to reduce physician's levels of inappropriate transfusion: what can be learned from a systematic review of the literature
  Transfusion, 2002
• Pharmaco‐economics of blood transfusion safety: review of the available evidence
  Vox Sanguinis, 2002
• US NAT yield: where are we after 2 years?
  Transfusion Medicine, 2002
• A policy analysis of major decisions relating to Creutzfeldt-Jakob disease and the blood supply.
  2001
• Pathogen inactivation of labile blood products
  Transfusion Medicine, 2001
• The case against universal WBC reduction (and for the practice of evidence-based medicine)
  Transfusion, 2000
• A model of the health and economic impact of posttransfusion hepatitis C: application to cost-effectiveness analysis of further expansion of HCV screening protocols
  Transfusion, 2000
• How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
  1992